Active Not Recruiting PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03386305

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

A Randomized Controlled Trial to Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

Sponsor: Albert Einstein Healthcare Network

Updated 8 times since 2018 Last updated: Jan 7, 2021 Started: Dec 13, 2017 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Post Liver Transplant, this trial is ongoing. The trial is conducted by Albert Einstein Healthcare Network and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Feb 2021 — Jul 2024 [monthly]

Active Not Recruiting PHASE2_PHASE3

Status: Recruiting → Active Not Recruiting
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE2_PHASE3
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3

▶ Show 3 earlier versions

Feb 2019 — Feb 2020 [monthly]

Recruiting PHASE2_PHASE3
Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE2_PHASE3
Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Albert Einstein Healthcare Network
Veloxis Pharmaceuticals

Data source: Albert Einstein Healthcare Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States